Clinical studies and trials confirmed the benefits of economic
knowledge
Frankly speaking, hypertension is still the leading modifiable risk
factor for death, but few cases achieve target BP control. Major
challenges include high prevalence of hypertension, over-consumption of
cardiovascular agents, low adherence to drug treatment, and resulting
uncontrolled BP. Five modifiable risk factors (body-mass index, systolic
BP, non-high-density lipoprotein cholesterol, smoking, and diabetes)
highly link to CVD and death from any cause [7]. Previous clinical
trials showed that home health education [8], self-monitoring blood
pressure [9-12], comprehensive screening [13], healthy lifestyle
interventions (e.g. diet of dark chocolate) [14-16], and lowering BP
agents (e.g., enalapril-folic acid, -sartan and others) [17-19] are
the feasibility and effectiveness, may not only reduce BP and
cardiovascular mortality and morbidity, but also represents a
cost-effective use of health care resources, and are beneficial in the
prevention of hypertension and major adverse cardiovascular events
(Figure 3).